Any room left for new antiplatelet agents in acute coronary syndrome?

被引：1
|
作者：
Collet, Jean-Philippe [1 ]
Montalescot, Gilles [1 ]
机构：
[1] CHU Pitie Salpetriere, Inst Cardiol, Bur 2 237, F-75013 Paris, France
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷 / 23期
关键词：
RECURRENT CARDIOVASCULAR EVENTS; THROMBIN-RECEPTOR ANTAGONIST; MYOCARDIAL-INFARCTION; CLOPIDOGREL; REDUCTION; INTERVENTION; VORAPAXAR;
D O I：
10.1093/eurheartj/eht127
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1699 / 1701
页数：3
相关论文
共 50 条
  • [41] Duration of dual antiplatelet therapy in acute coronary syndrome
    Wilson, Simon John
    Newby, David E.
    Dawson, Dana
    Irving, John
    Berry, Colin
    [J]. HEART, 2017, 103 (08) : 573 - 580
  • [42] New antiplatelet therapies for acute coronary syndromes
    Rich J.D.
    Wiviott S.D.
    [J]. Current Cardiology Reports, 2007, 9 (4) : 303 - 311
  • [43] Antiplatelet Treatment in the Secondary Prevention of Coronary and Cerebrovascular Disease: Is There any Place for Novel Agents?
    Ntalas, Ioannis V.
    Milionis, Haralampos J.
    Kei, Anastazia A.
    Kalantzi, Kallirroi I.
    Goudevenos, John A.
    [J]. ANGIOLOGY, 2014, 65 (06) : 473 - 490
  • [44] Protocol for the use of antiplatelet treatment in acute coronary syndrome
    Davila Fajardo, Cristina Lucia
    Gomez Pena, Celia
    Fernandez Oropesa, Carlos
    Salazar, Meritxel
    Sanchez Ramos, Jesus
    Martinez Huertas, Susana
    Ruiz Fuentes, Salvador
    Correa Vilchez, Concepcion
    Cabeza Barrera, Jose
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 252 - 252
  • [45] Oral antiplatelet therapy in the treatment of acute coronary syndrome
    Yalcin, Ridvan
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 : 4 - 11
  • [46] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
    Alexander, John H.
    Lopes, Renato D.
    James, Stefan
    Kilaru, Rakhi
    He, Yaohua
    Mohan, Puneet
    Bhatt, Deepak L.
    Goodman, Shaun
    Verheugt, Freek W.
    Flather, Marcus
    Huber, Kurt
    Liaw, Danny
    Husted, Steen E.
    Lopez-Sendon, Jose
    De Caterina, Raffaele
    Jansky, Petr
    Darius, Harald
    Vinereanu, Dragos
    Cornel, Jan H.
    Cools, Frank
    Atar, Dan
    Luis Leiva-Pons, Jose
    Keltai, Matyas
    Ogawa, Hisao
    Pais, Prem
    Parkhomenko, Alexander
    Ruzyllo, Witold
    Diaz, Rafael
    White, Harvey
    Ruda, Mikhail
    Geraldes, Margarida
    Lawrence, Jack
    Harrington, Robert A.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 699 - 708
  • [47] Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome
    Packard, Kathleen A.
    Campbell, Jennifer A.
    Knezevich, Jon T.
    Davis, Estella M.
    [J]. PHARMACOTHERAPY, 2012, 32 (03): : 244 - 273
  • [48] Antiplatelet agents used for early intervention in acute coronary syndrome: Myocardial salvage versus bleeding complications
    Aranki, Sary F.
    Body, Simon C.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (04): : 807 - U32
  • [49] Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome
    Kim, Kibum
    Lee, Todd A.
    Touchette, Daniel R.
    DiDomenico, Robert J.
    Ardati, Amer K.
    Walton, Surrey M.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (08): : 800 - 812
  • [50] COMPARISON OF NET CLINICAL EFFICACY OF NOVEL ANTIPLATELET AGENTS FOR ACUTE CORONARY SYNDROME USING BAYESIAN ANALYSIS
    Lang, Christopher
    Arora, Rohit
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
12345